Acceleron Pharma | XLRN

XLRN

121.83

Daily Change:

0.31%

Yearly:

18.28%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
AbbVie 116.08 0.18 0.16% 37.83%
Akebia Therapeutics 3.01 -0.04 -1.31% -74.23%
Alexion Pharmaceuticals 169.86 -0.05 -0.03% 75.26%
Amgen 251.30 1.95 0.78% 7.70%
Arena Pharmaceuticals 63.07 -1.23 -1.91% 26.52%
Bayer 53.91 0.42 0.79% -6.92%
Bluebird Bio 29.67 0.46 1.57% -50.01%
BioMarin Pharmaceutical 78.61 0.93 1.20% -14.55%
Clovis Oncology 5.67 -0.19 -3.24% -34.22%
Dicerna Pharmaceuticals 26.67 -1.83 -6.42% 16.72%
Exelixis 23.22 -0.75 -3.13% -8.22%
Gilead Sciences 66.54 0.03 0.05% -14.26%
GlaxoSmithKline 1,344.20 4.60 0.34% -19.73%
Johnson & Johnson 167.74 0.67 0.40% 13.65%
Karyopharm Therapeutics 8.14 0.03 0.37% -58.17%
Eli Lilly 193.60 0.95 0.49% 26.56%
Mirati Therapeutics 150.77 -0.74 -0.49% 61.42%
Neurocrine Biosciences 89.43 -2.17 -2.37% -17.91%
Novartis 79.08 0.20 0.25% -4.93%
Puma Biotechnology 9.68 0.04 0.41% -2.02%
Pfizer 39.19 -0.78 -1.95% 6.03%
PTC Therapeutics 40.33 -0.55 -1.35% -14.03%
Ultragenyx Pharmaceutical 115.71 9.70 9.15% 83.32%
Regeneron Pharmaceuticals 498.68 16.26 3.37% -10.92%
Rigel Pharmaceuticals 3.26 -0.21 -6.05% 78.14%
Sangamo BioSciences 10.40 0.01 0.10% 23.81%
TG Therapeutics 39.85 -1.63 -3.93% 113.79%
United Therapeutics 192.07 -6.07 -3.06% 71.52%
Vertex Pharmaceuticals 213.16 -0.71 -0.33% -21.05%
Acceleron Pharma 121.83 0.38 0.31% 18.28%

Indexes Price Day Year
NASDAQ 13632 50.42 0.37% 51.82%
Russell 2000 2241 0.05 0.002% 74.71%

XLRN:US
Assets
Cash and Equivalent
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
EPS Earnings Per Share
Equity Capital and Reserves
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Trade Creditors
Trade Debtors